On 1 February 2021, a million doses of the Oxford/AstraZeneca Covid-19 vaccine produced by the Serum Institute of India arrived at OR Tambo International Airport. Everything seemed set for the country’s vaccine rollout to kick off two or so weeks later.
But just a few days later on 7 February, the devastating news came that a study found the Oxford/AstraZeneca vaccine offered little or no protection against mild-to-moderate Covid-19 caused by the variant of SARS-CoV-2 prevalent in South Africa. Some argued that we should use the vaccine regardless since it might protect against severe disease and death, but the decision was taken not to use it and the vaccines were later sold.